NASDAQ: ORISOriental Rise Holdings Ltd Stock
$0.90+0.01 (+1.12%)
Updated Apr 30, 2025
ORIS Price
$0.90
Fair Value Price
N/A
Market Cap
$19.90M
52 Week Low
$0.84
52 Week High
$56.01
P/E
5.32x
P/B
0.28x
P/S
1.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$15.01M
Earnings
$2.09M
Gross Margin
26.2%
Operating Margin
14.34%
Profit Margin
13.9%
Debt to Equity
0.03
Operating Cash Flow
$3M
Beta
-0.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ORIS Overview
Oriental Rise Holdings Limited engages in production, processing, and trading of processed and refined tea leaves in People's Republic of China. The company was incorporated in 2019 and is based in Ningde, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ORIS's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Food
Industry Rating
B
ORIS
Ranked#34 of 49
Ranked#34 of 49
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.37 | A | |
| $7.20 | A | |
| $12.32 | A |
Be the first to know about important ORIS news, forecast changes, insider trades & much more!
ORIS News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ORIS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ORIS was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ORIS is good value based on its earnings relative to its share price (5.32x), compared to the US market average (29.18x)
P/E vs Market Valuation
ORIS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ORIS due diligence checks available for Premium users.
Valuation
ORIS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
5.32x
Industry
15.75x
Market
29.18x
ORIS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ORIS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ORIS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.28x
Industry
1.93x
ORIS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ORIS's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ORIS's Earnings (EBIT) of $2.15M... subscribe to Premium to read more.
Interest Coverage Financials
ORIS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$72.1M
Liabilities
$2.0M
Debt to equity
0.03
ORIS's short-term assets ($45.57M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ORIS's short-term assets ($45.57M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ORIS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ORIS's operating cash flow ($3.24M)... subscribe to Premium to read more.
Debt Coverage Financials
ORIS vs Food Stocks
Oriental Rise Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.